
	Mr. Gregory T. Schiffman, also known as Greg,MBA, CPA has been Chief Financial Officer and Executive Vice President of Finance of StemCells Inc. since January 1, 2014. Mr. Schiffman is responsible for all aspects of the Company&#39;s financing activities, financial reporting and controls, corporate communications, and investor relations. Mr. Schiffman served as Chief Financial Officer of Dendreon Corporation from December 2006 to August 2013 and Executive Vice President from December 2006 to December 31, 2013. He had primary responsibility for capital raising, financial reporting and controls, information technology, and investor relations. Mr. Schiffman served as Treasurer of Dendreon Corp. from December 14, 2006 to December 31, 2013 and served as its Executive Vice President from December 2010 to December 31, 2013. Mr. Schiffman served as Chief Financial Officer of Dendreon Corp. from December 14, 2006 to August 9, 2013. He served as Senior Vice President of Dendreon Corp., since December 14, 2006 until December 2010. Mr. Schiffman served as the Chief Financial Officer of Affymetrix Inc., from August 2001 to December 14, 2006 and also served as its Executive Vice President from February 2005 to December 14, 2006. He served as Senior Vice President of Affymetrix Inc., since October 2002. Mr. Schiffman joined Affymetrix in 2001. Mr. Schiffman served as Vice President of Finance for Affymetrix Inc. from March 2001 to August 2001 and Vice President since August 2001. Prior to Affymetrix, Mr. Schiffman served as Vice President and Controller of Applied Biosystems, Inc., since October 1998. From 1987 to 1998, Mr. Schiffman served various managerial and financial positions at Hewlett Packard Company and IBM. He has 20 years of Financial experience. He is a seasoned executive in the healthcare industry, with over fifteen years of experience leading the financial operations and strategy of global publicly-traded companies such as Affymetrix and Applied Biosystems. Before entering the healthcare field, Mr. Schiffman held roles of increasing responsibility within Hewlett Packard, where he served as controller of its European P.C. manufacturing and distribution operations in Grenoble, France, and as manufacturing manager and controller of its Netmetrix Division. Mr. Schiffman has been a Director at Nanomix, Inc. since November 29, 2005. He has been a Director of Xenogen Corporation since January 13, 2005. He served as a Director of Vnus Medical Technologies Inc. since April 7, 2006. He served as a Director of Entelos, Inc. since February 12, 2007. He served as a Director of IMPAC Medical Systems Inc., since February 2003. Mr. Schiffman holds a Master&#39;s in Business Administration from the J.L. Kellogg School of Management, Northwestern University and a Bachelor of Science degree in Accounting from DePaul University.
